Cargando…
Oral GLP1 Analog: Where Does the Tide Go?
T2D is a potentially preventable disease that has been ranked the seventh leading cause of mortality in the United States. There is strong evidence demonstrating that preventing type 2 diabetes is, in many cases, attainable through lifestyle intervention. Unfortunately, prediabetes is mostly overloo...
Autores principales: | Gardner, Hannah, Hamdy, Osama |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7780176/ https://www.ncbi.nlm.nih.gov/pubmed/33447122 http://dx.doi.org/10.1177/1179551420984130 |
Ejemplares similares
-
GLP-1a: Going beyond Traditional Use
por: Laurindo, Lucas Fornari, et al.
Publicado: (2022) -
13 Ebola virus: where does it come from and where is it going?
por: Murphy, Frederick A., et al.
Publicado: (1998) -
Semaglutide, a Once-Weekly Human GLP-1 Analog, Does Not Reduce the Bioavailability of the Combined Oral Contraceptive, Ethinylestradiol/Levonorgestrel
por: Kapitza, Christoph, et al.
Publicado: (2015) -
Moving Beyond Heading. How Does the Brain Reconcile where we are Going with where we Want to Go?
por: Wann, John
Publicado: (2011) -
Where is APC going?
por: Mimori-Kiyosue, Yuko, et al.
Publicado: (2001)